Precision Biopsy’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Precision Biopsy develops optical biopsy devices to improve the accuracy and reliability of prostate biopsies and the diagnosis of prostate cancer. Read more

2 Followers on Owler
2 Followers on Owler
2 Followers on Owler
2 Followers on Owler

Precision Biopsy develops optical biopsy devices to improve the accuracy and reliability of prostate biopsies and the diagnosis of prostate cancer. Read more

Amir Tehrani's photo - CEO of Precision Biopsy

CEO

Amir Tehrani

CEO Approval Rating

68/100

Founded:

2008

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees
Sector

Update Industry

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 11 a good estimate for Precision Biopsy's Employee count?

Acquisitions

No recent acquisitions found related to Precision Biopsy

Precision Biopsy Funding History

$33.6M$38.6M

Since Precision Biopsy was founded in 2008, it has participated in 2 rounds of funding. In total Precision Biopsy has raised $38.6M. Precision Biopsy's last funding round was on Oct 2016 for a total of $5.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Oct 2016
$5M
-
Equity
Oct 2015
$33.6M

Since Precision Biopsy was founded in 2008, it has participated in 2 rounds of funding. In total Precision Biopsy has raised $38.6M. Precision Biopsy's last funding round was on Oct 2016 for a total of $5.0M

Investments

No recent investments found related to Precision Biopsy

Precision Biopsy News

September 11, 2016Medical Device Network

Precision Biopsy gets IDE approval from FDA for ClariCore Biopsy System

Medical device company Precision Biopsy has obtained investigational device exemption (IDE) from the ... See more »
March 31, 2016Medical Devices Business Review

Precision Biopsy submits IDE application to FDA to expand clinical trial of ClariCore Biopsy system

Precision Biopsy announced that it submitted an application to the U.S. Food and Drug Administration ... See more »
March 29, 2016MassDevice

Precision Biopsy asks FDA to OK new ClariCore trial

Precision Biopsy said today it submitted an application to the FDA seeking a go-ahead to expand the t... See more »
October 6, 2015LASER FOCUS WORLD

Precision Biopsy set to speed commercialization of optical fiber-driven biopsy system for prostate cancer

An optical fiber-driven system for real-time classification of prostate cancer during biopsies has ra... See more »
October 6, 2015FINSMEs

Precision Biopsy Raises $33.6M in Equity Funding

Precision Biopsy, an Aurora, Colorado-based...... See more »

Social Media

Headquarters

12705 E Montview Blvd Ste 350 Suite 350

Aurora, Colorado80045

720-859-3553

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Precision Biopsy develops optical biopsy devices to improve the accuracy and reliability of prostate biopsies and the diagnosis of prostate cancer. Precision Biopsy was founded in 2008. Precision Biopsy's headquarters is located in Aurora, Colorado, U...

CEO

Precision Biopsy's CEO, Amir Tehrani, currently has an approval rating of 68%. Precision Biopsy's primary competitors are

Website

precisionbiopsy.com

Frequently Asked Questions about Precision Biopsy

  1. When was Precision Biopsy founded?

    Precision Biopsy was founded in 2008
  2. Who is Precision Biopsy's CEO?

    Precision Biopsy's CEO is Amir Tehrani
  3. How much revenue does Precision Biopsy generate?

    Precision Biopsy generates $2.2M in revenue
  1. How much funding does Precision Biopsy have?

    Precision Biopsy has historically raised $38.6M in funding
  2. Where is Precision Biopsy's headquarters?

    Precision Biopsy's headquarters is in Aurora Colorado, USA
  3. How many employees does Precision Biopsy have?

    Precision Biopsy has 11 employees